Get the Stockscreener App
6.67
11.35%
0.68
After Hours:
6.76
0.09
+1.35%
Electrocore Inc stock is traded at $6.67, with a volume of 129.63K.
It is up +11.35% in the last 24 hours and up +8.99% over the past month.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
See More
Previous Close:
$5.99
Open:
$5.96
24h Volume:
129.63K
Relative Volume:
2.01
Market Cap:
$55.33M
Revenue:
$32.03M
Net Income/Loss:
$-13.97M
P/E Ratio:
-3.9493
EPS:
-1.6889
Net Cash Flow:
$-8.25M
1W Performance:
+6.38%
1M Performance:
+8.99%
6M Performance:
+41.61%
1Y Performance:
+32.87%
1-Day Range:
$5.96
$6.79
1-Week Range:
$5.70
$6.79
52-Week Range:
$4.16
$8.64
Electrocore Inc Stock (ECOR) Company Profile
Name
Electrocore Inc
Sector
Industry
Phone
973-290-0097
Address
200 FORGE WAY, ROCKAWAY
Compare ECOR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ECOR
Electrocore Inc
|
6.67 | 49.69M | 32.03M | -13.97M | -8.25M | -1.6889 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-14-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-14-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Sep-26-19 | Resumed | Cantor Fitzgerald | Neutral |
| May-30-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-15-19 | Downgrade | BTIG Research | Buy → Neutral |
| May-09-19 | Initiated | Noble Capital Markets | Outperform |
| Sep-21-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Electrocore Inc Stock (ECOR) Latest News
ElectroCore touts 30% growth outlook, VA opportunity at LD Micro Conference - MSN
ElectroCore CFO sells $19,500 in shares - Investing.com India
ElectroCore CFO sells $19,500 in shares By Investing.com - Investing.com Australia
electroCore (ECOR) CFO sells 3,000 shares to cover RSU taxes - Stock Titan
electroCore Touts 30% Growth Outlook, VA Opportunity at LD Micro Conference - Yahoo Finance
Relay Therapeutics (RLAY) surges 16.4%: Is this an indication of further gains? - MSN
ECOR: Rapid growth, unique vagus nerve tech, and new partnerships drive future expansion - TradingView
electroCore (ECOR) Stock: Down -2.49%, Support Test at $5.96 2026-05-17Dealer Delta - Newser
ElectroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026 - marketscreener.com
electroCore (ECOR) Drops -5.29% — Key Support at $5.79 2026-05-15Imbalance Zone - Newser
electroCore (ECOR) Q1 2026 Earnings Transcript - AOL.com
ECOR Stock Price, Quote & Chart | ELECTROCORE INC (NASDAQ:ECOR) - ChartMill
Vagus Nerve Stimulators Market to Reach USD 1.86 Billion by 2033 - openPR.com
ECOR (NASDAQ) brokered sale notice: 45,000 shares valued $291,600 - Stock Titan
Quell device shows pain reduction in fibromyalgia study By Investing.com - Investing.com India
electroCore (ECOR) Reports Positive Fibromyalgia Trial Results - GuruFocus
Quell device shows pain reduction in fibromyalgia study - Investing.com
electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia - The Manila Times
electroCore Announces Publication in JAMA Highlighting the - GlobeNewswire
Wearable nerve stimulator eases fibromyalgia pain in JAMA trial - Stock Titan
Q2 Earnings Forecast for electroCore Issued By HC Wainwright - MarketBeat
Brokers Set Expectations for electroCore Q2 Earnings - MarketBeat
Number of shareholders of electroCore, Inc. – NASDAQ:ECOR - TradingView
Q1 Earnings Forecast for electroCore Issued By HC Wainwright - MarketBeat
ElectroCore reaffirms 2026 revenue guidance of ~30% growth while targeting deeper VA utilization - MSN
electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026 - Sahm
electroCore to present at LD Micro Invitational XVI on May 18, 2026, highlighting bioelectronic medicine advances - Pluang
electroCore to Present at LD Micro Invitational XVI Conference on May 18, 2026 - geneonline.com
Analysts Are Bullish on These Healthcare Stocks: Electrocore (ECOR), Warby Parker (WRBY) - The Globe and Mail
Maxim Group Maintains ElectroCore(ECOR.US) With Buy Rating, Maintains Target Price $12 - Moomoo
How electroCore (ECOR) responds when competition intensifies (Momentum Fading) 2026-05-08Late Breakout - Newser
electroCore (ECOR) Reports Strong Q1 Revenue Growth - GuruFocus
ECOR Forecasts 30% Revenue Growth for 2026 - GuruFocus
ElectroCore Q1 earnings preview - MSN
electroCore, Inc. (NASDAQ:ECOR) Q1 2026 Earnings Call Transcript - Insider Monkey
electroCore, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
electroCore Q1 2026 Earnings Call Transcript - MarketBeat
electroCore reports Q1 EPS (59c) vs. (47c) last year - TipRanks
electroCore Q1 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: Electrocore Q1 2026 revenue hits record high By Investing.com - Investing.com Canada
electroCore, Inc. (ECOR) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
Veterans Affairs drives electroCore's record quarter; Truvaga enters UK - Stock Titan
electroCore (NASDAQ: ECOR) grows Q1 2026 sales but warns on going concern - Stock Titan
electroCore Announces First Quarter 2026 Financial Results - The Manila Times
ElectroCore Announces First Quarter 2026 Financial Results - marketscreener.com
ElectroCore, Inc. Reaffirms Earnings Guidance for the Full Year of 2026 - marketscreener.com
Hilve Holdings discloses 6.4% stake in electroCore (ECOR) - Stock Titan
Daniel Goldberger lists sales; Charles Schwab (ECOR) Form 144 details - Stock Titan
Electrocore Inc Stock (ECOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):